Ironwood Pharmaceuticals Q3 Adj. EPS $0.36 Beats $0.32 Estimate, Sales $133.040M Beat $121.567M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.32 by 12.5 percent. This is a 50 percent increase over earnings of $0.24 per share
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.32 by 12.5 percent. This is a 50 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $133.040 million which beat the analyst consensus estimate of $121.567 million by 9.44 percent. This is a 9.00 percent increase over sales of $122.060 million the same period last year.